Baylor Health Care SystemAbout B
 
Need something? Call us: 1.800.4BAYLOR(1.800.422.9567)
Text Size:

Allogeneic Islet Cell Transplant Research 

Type 1 Diabetes

Allogeneic islet cell transplant - an experimental protocol - aims specifically at patients with long-term disease who have difficulty controlling their blood sugar.

In patients with type 1 diabetes, islet cells from a deceased donor are extracted and then infused into the patient's liver, where they may be able to produce insulin.

Successful allo islet cell transplantation may represent a pivotal development in diabetes management, potentially providing patients with better blood glucose control.

Typical candidates for allo islet cell transplantation at Baylor have:

  • Type 1 diabetes for more than five years
  • Diabetes related complications such as frequent blackouts due to improper dose of insulin
  • Early signs of kidney problems.

Islet cell transplantation for diabetes is still considered experimental and can only be conducted at approved centers like Baylor, which is equipped with a FDA approved islet cell processing facility and well-trained clinicians to handle complex and long-term medical needs of transplant patients.